No Data
No Data
$NKTR Stock Is up 9% Today. Here's What We See in Our Data.
Nektar Says FDA Grants Fast-Track Designation to Atopic Dermatitis Treatment
12 Health Care Stocks Moving In Monday's Pre-Market Session
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis
Down -38.51% in 4 Weeks, Here's Why Nektar (NKTR) Looks Ripe for a Turnaround
Nektar Names Kotzin Interim Chief Medical Officer